| BRIEF COMMUNICATION |
|
| Year : 2012 | Volume
: 60
| Issue : 4 | Page : 311-313 |
Managing bevacizumab-induced intraocular inflammation
Subijay Sinha, Nagender Vashisht, Pradeep Venkatesh, Sat Pal Garg
Dr. Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, New Delhi, India
Correspondence Address:
Subijay Sinha
Vitreo-Retina Services, Dr. RP Centre, AIIMS, New Delhi - 110 029
India
DOI: 10.4103/0301-4738.98712
The outcome of four cases of sterile endophthalmitis that developed after intravitreal injections of bevacizumab has been reported here. All four eyes received 1.25 mg/0.05 ml intravitreal bevacizumab from 0.2-ml aliquots for different etiologies. The inflammation predominantly involved the anterior chamber with mild vitreous reaction. All patients were culture negative and regained preinjection visual acuity and were culture negative following intravitreal antibiotic administration. This report highlights that intravitreal bevacizumab can cause sterile endophthalmitis and this has to be kept in mind, and clinical judgment should be used to differentiate it from infective endophthalmitis.
[FULL TEXT] [PDF]*
|
